In what could be very good news for the immunocompromised, an antibody cocktail tested at the University of Virginia School of Medicine appears to offer long-lasting protection from COVID-19. The cocktail, manufactured by Regeneron Pharmaceuticals, reduced the risk of COVID-19 infection by more than 80% for more than eight months, the company announced in a […]
Posts tagged with "University of Virginia School of Medicine"
Cold Sore Flareup Triggers
Virus Highjacks Important Immune Response, UVA Discovery Reveals Researchers at the University of Virginia School of Medicine have shed light on what causes herpes simplex virus to flare up, explaining how stress, illness and even sunburn can trigger unwanted outbreaks. The discovery could lead to new ways to prevent cold sores and recurrent herpes-related eye disease from […]
UVA’s DNA Discovery
Scientists have identified a group of drugs that may help stop a leading cause of vision loss after making an unexpected discovery that overturns a fundamental belief about DNA. The drugs, known as Nucleoside Reverse Transcriptase Inhibitors, or NRTIs, are commonly used to treat HIV. The new discovery suggests that they may be useful against […]
Blood Discovery Research x UVA
Blood Discoveries Advance Effort to Grow Organs, Battle Cancer New Research Reveals Important Insights Into How Our Bodies Make Blood CHARLOTTESVILLE, V.A.– Pioneering research into how our bodies manufacture the cells that make blood has moved us closer to regrowing tissues and organs. These findings also may let doctors grow the cells for transplantation into people […]
COVID-19 Trial Tests if Common Drug Can Keep Patients Out of Hospital
At-risk people diagnosed with COVID-19 across the United States and Canada can participate in a clinical trial testing whether a common drug can keep them from getting sicker and keep them out of the hospital. The trial, conducted by Washington University School of Medicine in St. Louis, is based on a discovery by the University […]
UVA Tests Different Approach to Managing Type 2 Diabetes
A researcher at the University of Virginia School of Medicine is testing what he calls a “radically different” approach to managing type 2 diabetes for those who can’t or don’t want to lose weight. Daniel Cox, PhD, professor of psychiatry and internal medicine, said his program “flies in the face of conventionality” in that it […]
UVA on Battling Diseases by Exercise
A top exercise researcher and colleagues at the University of Virginia School of Medicine have launched an ambitious effort to understand the whole-body benefits of exercise so that doctors can use that information to prevent and treat disease. Zhen Yan, PhD, and his collaborators aim to identify the sources, functions and targets of the molecules […]
Antidepressant x COVID-19
Based on a trial from the University of Virginia School of Medicine, the antidepressant fluvoxamine appears to prevent COVID-19 infections from worsening, even keeping patients out of the hospital. The clinical trial was conducted by the Washington University School of Medicine in St. Louis. Fluvoxamine was compared with a placebo in 152 adult patients who […]
Cancer Discovery Reveals Key Process in Tumor Formation
A discovery from the University of Virginia School of Medicine may open the door to an entirely new approach to treating cancer: by disrupting a vital condensation process inside cancer cells. Researchers led by Hao Jiang, PhD, of UVA’s Department of Biochemistry and Molecular Genetics, discovered that cancer cells are exceptionally dependent on the proper […]
The Coma Plan – New Treatment for Comatose Patients
Leading coma experts have created an ambitious plan to help doctors better care for comatose patients and answer that most awful question: “Will my loved one wake up?” To clarify, the three-part plan outlines key steps physicians and researchers should take in the coming years to improve patient care and deepen our understanding of coma […]